The effect of vascular endothelial growth factor in the progression of bladder cancer and diabetic retinopathy. - Wikidata - wikimedia - TriplyDB

The effect of vascular endothelial growth factor in the progression of bladder cancer and diabetic retinopathy.

The effect of vascular endothelial growth factor in the progression of bladder cancer and diabetic retinopathy.

http://www.wikidata.org/entity/Q38103868

about

Therapeutic implications of curcumin in the prevention of diabetic retinopathy via modulation of anti-oxidant activity and genetic pathways.Implication of vascular endothelial growth factor A and C in revealing diagnostic lymphangiogenic markers in node-positive bladder cancer.Therapeutic Implications of Black Seed and Its Constituent Thymoquinone in the Prevention of Cancer through Inactivation and Activation of Molecular Pathways.Expressional analysis of p16 and cytokeratin19 protein in the genesis of oral squamous cell carcinoma patients Association of VEGF gene polymorphisms with diabetic retinopathy: a meta-analysis.Effect of Korean Red Ginseng treatment on the gene expression profile of diabetic rat retina.Implication of androgen receptor in urinary bladder cancer: a critical mini review.Streptozotocin induced diabetic retinopathy in rat and the expression of vascular endothelial growth factor and its receptor.Ellagic Acid Inhibits Bladder Cancer Invasiveness and In Vivo Tumor Growth Therapeutic effects of date fruits (Phoenix dactylifera) in the prevention of diseases via modulation of anti-inflammatory, anti-oxidant and anti-tumour activity.Incorporating VEGF-targeted therapy in advanced urothelial cancer.Angiodrastic Chemokines in Colorectal Cancer: Clinicopathological Correlations.Retinal angiotensin II and angiotensin-(1-7) response to hyperglycemia and an intervention with captopril

P2860

Q31146840-76D6E16E-068A-4F22-9751-B2244C011E05 Q33591719-B3064A13-5A2F-4A73-9482-FB195A92A45D Q33736242-1011EFF3-049D-4034-A12B-FFD1836D1FD2 Q33911091-8B78F35A-99FF-45A8-8B30-BEBED7E097E9 Q35078329-24A664AD-D343-4977-A542-F57130788842 Q36437781-D5EA1420-B030-4173-AA63-99052080DFB9 Q37172372-00E01CD8-16C4-49BB-949F-6B5D2126E9BD Q37256814-2A3B0B65-C038-4C6C-B97C-C0B2CE019299 Q37463406-36AD4977-8898-4D88-9F22-1F6A4A8D6FB1 Q37711426-F7F97277-E734-4F87-BDB4-DFC4771164D7 Q38756931-0F287C98-171C-4CE0-9A5B-4F724284D767 Q54969912-F2ABE6D8-A1C9-472E-A421-32882FECE3A4 Q58730421-150C5F7E-FBD6-48CB-9A9C-27486BB81E90

P2860

The effect of vascular endothelial growth factor in the progression of bladder cancer and diabetic retinopathy.

http://www.wikidata.org/entity/Q38103868

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

The effect of vascular endothe ...... ncer and diabetic retinopathy.

@en

type

label

The effect of vascular endothe ...... ncer and diabetic retinopathy.

@en

prefLabel

The effect of vascular endothe ...... ncer and diabetic retinopathy.

@en

P1433

Q38103868-0AB36C41-5B7A-4B95-85C7-CCA64802B271

P1476

Q38103868-6C58E3F6-825E-4688-8064-937D0F223273

P2093

Q38103868-249E6204-71FD-4148-AA88-58F8E8808875

Q38103868-9895EF7E-240D-424E-989F-7774BA3C1D9F

Q38103868-ECC960E7-81AE-4BA5-8193-01CEAD39A0E2

Q38103868-F4BBAF28-BCEA-415E-972A-EFAED1F515EC

P2860

Q38103868-02ACA718-880E-4B32-B3A9-D87F28EB5EBC

Q38103868-031FF4EE-F7B8-4E1D-AF5D-6E5D7E9AC046

Q38103868-0356EE30-8BAB-491F-89B8-B958B2DC0AA2

Q38103868-0A505A30-B2B3-4F41-9D67-D64EF13FB99D

Q38103868-0E6D45CD-07A7-497F-8FD8-06CD7C0F69F2

Q38103868-11944AAD-9FC7-4F12-B79A-5E4906555DE3

Q38103868-13DF91A4-197E-4505-837D-D6135D8A9C62

Q38103868-19FC5DCA-B1CD-4E92-91C2-878C3B3FE836

Q38103868-1BE57780-42AB-4949-AE99-84EE36216B3D

Q38103868-1BEFBB70-1048-48CC-A543-D687B73E7BDF

P304

Q38103868-9080B3BB-6918-482F-A233-F6D666FDE1B0

P31

Q38103868-7F41EF89-7D16-4D5A-99EA-31DE21990E8E

P433

Q38103868-A11DAE57-44EE-44AB-934A-F2439A1CEEAC

P478

Q38103868-12D4ADB9-9FA1-4A36-9A64-8A30DF2671D2

P577

Q38103868-2DC0F45F-8D0C-4EA6-8D69-D7A4EEAFFCDD

P698

Q38103868-15869D1E-12CB-4D46-8629-248DEB056E45

P921

Q38103868-229E43FF-FD3E-46EC-BF99-0343DDE41E0A

P932

Q38103868-922DDAD1-DB23-4E09-99DD-031471467C90

P1433

International Journal of Clinical and Experimental Medicine

P1476

The effect of vascular endothe ...... ncer and diabetic retinopathy.

@en

P2093

Amjad A Khan

http://www.w3.org/2001/XMLSchema#string

Arshad H Rahmani

http://www.w3.org/2001/XMLSchema#string

Salah Mesalhy Aly

http://www.w3.org/2001/XMLSchema#string

Yousef H Aldebasi

http://www.w3.org/2001/XMLSchema#string

P2860

Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family

Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1

Genomic organization of the mouse and human genes for vascular endothelial growth factor B (VEGF-B) and characterization of a second splice isoform

Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1

The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)

Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN

Interaction of the Flt-1 tyrosine kinase receptor with the p85 subunit of phosphatidylinositol 3-kinase. Mapping of a novel site involved in binding

Proteolytic processing regulates receptor specificity and activity of VEGF-C.

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

P304

239-251

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23641300

http://www.w3.org/2001/XMLSchema#string

P921

P932

3631548

http://www.w3.org/2001/XMLSchema#string